Ibudilast reduces alcohol drinking in multiple animal models of alcohol dependence.
about
A New Outlook on Mental Illnesses: Glial Involvement Beyond the GlueAstrocytic dysfunction and addiction: consequences of impaired glutamate homeostasisA Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.Mechanisms of neuroimmune gene induction in alcoholismGlutamatergic transmission in drug reward: implications for drug addictionInhibition of phosphodiesterase 4 reduces ethanol intake and preference in C57BL/6J micePhosphodiesterase regulation of alcohol drinking in rodents.Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial.Tigecycline Reduces Ethanol Intake in Dependent and Nondependent Male and Female C57BL/6J Mice.Reduction of alcohol drinking of alcohol-preferring (P) and high-alcohol drinking (HAD1) rats by targeting phosphodiesterase-4 (PDE4).The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteersIL-1 receptor signaling in the basolateral amygdala modulates binge-like ethanol consumption in male C57BL/6J mice.Neuroimmune mechanisms of alcohol and drug addiction.Discovery, Development, and Adoption of Medications to Treat Alcohol Use Disorder: Goals for the Phases of Medications DevelopmentThe Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate HomeostasisIbudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient studyTargeting the Toll of Drug Abuse: The Translational Potential of Toll-Like Receptor 4.Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models.The phosphodiesterase-4 inhibitor roflumilast decreases ethanol consumption in C57BL/6J mice.Molecular mechanisms underlying alcohol-drinking behavioursImpact of the Innate Immune Response in the Actions of Ethanol on the Central Nervous System.The neuroimmune transcriptome and alcohol dependence: potential for targeted therapies.The role of neuroimmune signaling in alcoholism.Rat animal models for screening medications to treat alcohol use disorders.Modulation of Binge-like Ethanol Consumption by IL-10 Signaling in the Basolateral Amygdala.Ibudilast attenuates expression of behavioral sensitization to cocaine in male and female rats.Evaluation of TLR4 Inhibitor, T5342126, in Modulation of Ethanol-Drinking Behavior in Alcohol-Dependent Mice.Phosphodiesterase 4 inhibitors and drugs of abuse: current knowledge and therapeutic opportunities.Glial and neuroinflammatory targets for treating substance use disorders.Attenuation of ethanol abstinence-induced anxiety- and depressive-like behavior by the phosphodiesterase-4 inhibitor rolipram in rodents.Targeting Phosphodiesterases in Pharmacotherapy for Substance Dependence.Activated mesenchymal stem cell administration inhibits chronic alcohol drinking and suppresses relapse-like drinking in high-alcohol drinker rats.Advances in Pharmacotherapy Development: Human Clinical Studies.Ethanol and Cytokines in the Central Nervous System.Low Vs. High Alcohol: Central Benefits Vs. Detriments.Imaging the neuroimmune response to alcohol exposure in adolescent baboons: a TSPO PET study using (18) F-DPA-714.Medications for alcohol use disorders: An overview.Apremilast Alters Behavioral Responses to Ethanol in Mice: I. Reduced Consumption and Preference.Innate Immune Signaling and Alcohol Use Disorders.Cyclic nucleotide phosphodiesterases: potential therapeutic targets for alcohol use disorder.
P2860
Q26770756-D920CC0A-B2B3-462E-934B-D069F07FF270Q26996339-8F96A2C2-51A8-46B9-B61F-C1502B7EA41EQ28068256-9E333512-C000-4474-BF86-C722A6082B87Q28085043-E9901C13-B223-49F7-933F-B2016EFE7FF5Q28112161-0B1863C8-8864-48E5-9CE8-4D377550A1B5Q28386651-21DA8A70-FDEE-4B93-8EE6-DC4E33833621Q28394978-5E6BE9C6-1FB5-44AC-B229-F931C29A08FFQ34549370-D3CA1709-4AE2-4EAF-89E1-50700E3207ADQ34679845-4CD30211-AF39-4BF1-8B7C-CF81DFCD00EBQ35738103-BF1F0264-6744-402A-B868-50F08ABCF2FBQ36279074-DCFCE6DB-9BED-4AC4-8401-EBA4D7E78221Q36372796-8786C740-36EB-42C0-B967-AED7C76645BCQ36720931-F6F0C138-37F2-4130-9E6B-A4B13EB137D0Q37059221-C8C10DAE-5729-4461-8030-6BDB0EF4D07BQ37062547-F11CFEDF-2A6E-4B37-A0A6-5B1BCD62184BQ37698675-D8657704-59F7-4F2B-956A-070E711E84BBQ38506636-64A29C68-0355-42B5-AB22-7CDB6B919427Q38718932-CD45AB2E-B577-4C7D-8CC5-C95206F968C6Q38801216-406DB557-EEE7-42BD-95A2-34015A39C970Q38904980-EBFF12F3-AB36-4145-9853-909B40698666Q38960163-3F8146C1-A356-4D23-84D2-51D169BDC214Q39029383-278E0649-3E26-4B32-B868-6C5FE7088375Q39118808-627A0B7A-EA1F-423D-92D9-227C5720DEC3Q39142990-452114C6-BD2F-4AB0-A463-E9D685CC46B1Q39377543-3AD2C250-00AE-4D2F-8E8E-6C1305D577E9Q39655812-80A76B03-4E42-4F3A-AF90-DDDCDB989646Q39789782-69D94A19-7C86-4336-8DA1-F983AA4B3BDEQ42365240-9A4A1AD5-3593-4E50-9936-867CBDC9BDA3Q43076075-F48BD930-7705-4E43-A112-9B6A84903D47Q45064230-9BA66024-6828-43A8-B7E2-A6625F69EAF1Q45068639-AE87093B-4CDA-4B9E-AA6C-0E87F77D1E6BQ46281623-46C96F23-0408-47F4-994B-8D9329EE6404Q47182010-B178A9F3-7F3F-40A1-989F-15B326D03C7CQ47298502-BBFB7D90-5C78-4D3A-B4D5-3243BB041911Q47663680-5DAA6995-C485-4C99-A51A-1D7F9F1BF780Q47750146-9A6474C2-2D0F-472A-A80A-FBF178F317A0Q47942161-746A2E95-3332-430E-8179-89A993459C47Q51749016-2ABA8D24-29A0-4468-8002-722D64D7ED4FQ52316042-C0A88629-6821-4855-A50C-80B244323880Q52584145-56C50276-5DF1-480E-974A-CCF6D895043D
P2860
Ibudilast reduces alcohol drinking in multiple animal models of alcohol dependence.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Ibudilast reduces alcohol drinking in multiple animal models of alcohol dependence.
@ast
Ibudilast reduces alcohol drinking in multiple animal models of alcohol dependence.
@en
type
label
Ibudilast reduces alcohol drinking in multiple animal models of alcohol dependence.
@ast
Ibudilast reduces alcohol drinking in multiple animal models of alcohol dependence.
@en
prefLabel
Ibudilast reduces alcohol drinking in multiple animal models of alcohol dependence.
@ast
Ibudilast reduces alcohol drinking in multiple animal models of alcohol dependence.
@en
P2093
P2860
P921
P356
P1433
P1476
Ibudilast reduces alcohol drinking in multiple animal models of alcohol dependence.
@en
P2093
Changhai Cui
Howard C Becker
Kelle M Franklin
Kirk W Johnson
Marcelo F Lopez
Richard L Bell
P2860
P356
10.1111/ADB.12106
P407
P577
2013-11-11T00:00:00Z